MedPath

Validation of a NICS Method Using the Culture Medium

Completed
Conditions
Chromosome Abnormality
Abnormality
Registration Number
NCT03879265
Lead Sponsor
Instituto Bernabeu
Brief Summary

This study aims to validate a non-invasive method of chromosomal screening (NICS), based on the Multiple Annealing and Looping Based Amplification Cycles- Next-generation Sequencing (MALBAC-NGS) technology, in order to determine the chromosomal endowment of a blastocyst from the DNA of the embryonic culture medium.

The chromosomal status of the embryo from an embryo biopsy of trophoectoderm will be established (usual clinical practice), the chromosomal endowment from the DNA of the embryonic culture medium will be determined, and the results using the NICS and the conventional invasive method (Preimplantation Genetic Testing for Aneuploidy \[PGT-A\]) will be compared.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
50
Inclusion Criteria
  • Treatment by oocyte donation or own oocyte nd preimplantation genetic screening of aneuploidies (PGT-A).
  • Embryonic cryopreservation.
  • Informed consent signature
Exclusion Criteria
  • Embryo transfer without embryo freezing
  • Embryonic block.
  • Bad embryo quality.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Presence of MosaicismAt Day 5-6 after FIV

Presence of mosaicism

Quality value of NICS DLRSAt Day 5-6 after FIV

Quality value of noninvasive chromosome screening (NICS) derivative Log Ratio Spread (DLRS)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Instituto Bernabeu

🇪🇸

Alicante, Spain

Instituto Bernabeu
🇪🇸Alicante, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.